4//SEC Filing
ALLEN LEE F MD PhD 4
Accession 0001209191-19-040368
CIK 0001685071other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:56 PM ET
Size
5.5 KB
Accession
0001209191-19-040368
Insider Transaction Report
Form 4
ALLEN LEE F MD PhD
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-07-01$14.19/sh−1,957$27,770→ 10,613 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.98 to $14.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Dova Pharmaceuticals Inc.
CIK 0001685071
Entity typeother
Related Parties
1- filerCIK 0001408474
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:56 PM ET
- Size
- 5.5 KB